These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31422145)

  • 1. Considerations for Clinical Trials Targeting the Myocardial Interstitium.
    Lewis GA; Dodd S; Naish JH; Selvanayagam JB; Dweck MR; Miller CA
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2319-2331. PubMed ID: 31422145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Myocardial Interstitium: The Principal Therapeutic Target of the 21st Century?
    Schelbert EB; Chandrashekhar Y
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2369-2371. PubMed ID: 31699304
    [No Abstract]   [Full Text] [Related]  

  • 3. Why Clinicians Should Care About the Cardiac Interstitium.
    Schelbert EB; Butler J; Diez J
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2305-2318. PubMed ID: 31422140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.
    Schelbert EB; Sabbah HN; Butler J; Gheorghiade M
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28512159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on current progress in cardiac fibrosis.
    Al Hattab D; Czubryt MP
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding of fibrosis in genetic cardiomyopathies.
    Eijgenraam TR; Silljé HHW; de Boer RA
    Trends Cardiovasc Med; 2020 Aug; 30(6):353-361. PubMed ID: 31585768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications.
    Chapman RE; Spinale FG
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H1-H10. PubMed ID: 14684355
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.
    Podlesnikar T; Delgado V; Bax JJ
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):97-112. PubMed ID: 28642994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of myocardial fibrosis in severe aortic stenosis: study protocol for a prospective observational multi-center study (FIB-AS).
    Balčiūnaitė G; Palionis D; Žurauskas E; Skorniakov V; Janušauskas V; Zorinas A; Zaremba T; Valevičienė N; Aidietis A; Šerpytis P; Ručinskas K; Sogaard P; Glaveckaitė S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):275. PubMed ID: 32513178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.
    Ugander M; Oki AJ; Hsu LY; Kellman P; Greiser A; Aletras AH; Sibley CT; Chen MY; Bandettini WP; Arai AE
    Eur Heart J; 2012 May; 33(10):1268-78. PubMed ID: 22279111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential reduction of interstitial myocardial fibrosis with renal denervation.
    Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
    J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics-based therapeutics for myocardial fibrosis.
    Li X; Yang Y; Chen S; Zhou J; Li J; Cheng Y
    Life Sci; 2021 Apr; 271():119186. PubMed ID: 33577852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis.
    Chin CWL; Everett RJ; Kwiecinski J; Vesey AT; Yeung E; Esson G; Jenkins W; Koo M; Mirsadraee S; White AC; Japp AG; Prasad SK; Semple S; Newby DE; Dweck MR
    JACC Cardiovasc Imaging; 2017 Nov; 10(11):1320-1333. PubMed ID: 28017384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interstitium in the Hypertrophied Heart.
    Halliday BP; Prasad SK
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2357-2368. PubMed ID: 31542527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease.
    Díez J
    Circ J; 2008; 72 Suppl A():A8-12. PubMed ID: 18772529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.